RSS Amplifier

DailyDropout.FYI · Jul 14, 2026

🚀 Queue: Bottle In, Prescription Out

0
Sign in to vote or save

DailyDropout.FYI · DailyDropout.FYI

Walk up, scan a QR code, and about 60 seconds later your prescription drops out — counted, labeled, and verified, with no pharmacist behind the counter. That's the machine Queue just came out of stealth with $18.6M to build. Let's check them out!

Nearly one in three U.S. pharmacies has closed since 2010, stranding roughly 50 million Americans in "pharmacy deserts" with nowhere convenient to fill a script. The counters still open are buckling: pharmacy schools are on track to graduate 3,000–4,000 fewer pharmacists than the country needs over the next five to six years, and technician vacancies run as high as 40%. Worse, the scarce experts spend their days on mechanical work — counting pills, printing labels, double-checking the vial — instead of with patients.

Enter Queue, a Palo Alto startup building what it calls the world's first fully autonomous robotic pharmacy. Its "Queue Unit" takes sealed wholesale bottles in one end and pushes filled, verified prescription vials out the other — no on-site pharmacist required — covering the ~250 most-prescribed U.S. medications, filling a script in under a minute, and running around the clock. Founders Nick Desai (CEO, who earlier built house-call startup Heal to $200M+ raised) and Josh Liu (CTO, ex-Tesla, Zipline, and Waymo) just brought it out of stealth with an $18.6M haul — a $12.6M seed led by AlleyCorp on top of a $6M Riot Ventures pre-seed. Queue says the unit dispenses at up to 96% lower cost, and it's already signed a major national pharmacy chain.

The “Queue Unit”: sealed bottles in, filled and verified vials out. Source: Queue
  • 🌐 Website: queue.inc

  • 🏷️ Launched: Out of stealth, June 2026

  • 👥 Founders: Nick Desai (CEO), Josh Liu (CTO)

  • 💰 Stage: Seed — $18.6M total ($12.6M seed led by AlleyCorp + $6M pre-seed led by Riot Ventures; House Capital, Ubiquity Ventures, Grep Ventures & Banter Capital joining)

  • 📈 Traction: Working prototype deployed; one major national pharmacy chain signed; wide-scale rollout targeted for ~January 2027

  • 🔮 Tech Trend: Physical AI / healthcare automation

  • 🎯 Target Market: Retail pharmacy chains, hospitals, and rural / pharmacy-desert communities

  • 🏢 Location: Palo Alto, CA (~20-person team)

Queue has raised $18.6M — a $6M pre-seed plus a $12.6M seed
$6M pre-seed + $12.6M seed = $18.6M total raised. Source: Queue / Business Wire, June 2026
  • 📈 The crisis is the tailwind: Automating a pharmacy used to be a nice-to-have; now it's survival. With a third of U.S. pharmacies gone since 2010 and chains bleeding on reimbursements, a unit that fills scripts at a fraction of the cost lands exactly when the industry needs it. The pharmacy-automation market is projected to grow from $6.23B in 2023 to $10.0B by 2030 (7.1% CAGR) — and that's the equipment slice of a ~$670B U.S. retail-pharmacy market Queue is ultimately aiming at.

  • 🤖 It removes the pharmacist from the wrong job, not the right one: Incumbents like Omnicell and Amazon Pharmacy speed up a pharmacy that still needs a licensed pharmacist standing in it. Queue's whole-machine bet is different — the Queue Unit counts, labels, and computer-vision-verifies on its own, so it can go where you can't staff a pharmacy at all. As CTO Josh Liu puts it, they're taking "the work off their plate that never needed a human," letting pharmacists get back to counseling patients.

  • 👫 Founders who actually ship hardware: Desai is a six-time founder who scaled Heal into millions of house calls, while Liu ran engineering on flying blood-delivery drones at Zipline and hardware at Tesla. Their ~20-person team pulls from Rivian, Waymo, and aerospace — exactly the people who know how to make a physical machine hit 100% reliability, which is the only bar a pharmacy can pass.

Nearly 1 in 3 U.S. pharmacies have closed since 2010
Nearly 1 in 3 U.S. pharmacies have closed since 2010. Source: USC / UC Berkeley, Health Affairs (2024)

The challenge will be the regulators. Most state pharmacy boards still require a licensed pharmacist to verify the final fill — often allowed remotely, but roughly 22 states restrict or don't clearly authorize telepharmacy at all, so a national rollout means 50 separate compliance regimes. DEA rules also keep controlled substances (a big slice of scripts) off an autonomous kiosk for now, and well-capitalized incumbents like Omnicell and Amazon keep a pharmacist in the loop and won't cede the counter quietly. "Fully autonomous" has to survive contact with all three.

Pharmacy automation market growing from $6.23B in 2023 to $10.0B by 2030
Pharmacy automation: $6.23B (2023) → $10.0B by 2030, 7.1% CAGR. Source: MarketsandMarkets, 2025

Read the original on dailydropout.substack.com

Comments

Nothing yet. Say the first thing.

    Sign in to join the conversation.